UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Rapidly progressive endomyocardial fibrosis and heart failure in a 17-year-old female with limited cutaneous systemic sclerosis

Scandinavian journal of rheumatology, 2019-07, Vol.48 (4), p.336-337

2019

Volltextzugriff (PDF)

Influence of low socioeconomic status on mortality in granulomatosis with polyangiitis

Scandinavian journal of rheumatology, 2020-05, Vol.49 (3), p.221-224

2020

Volltextzugriff (PDF)

Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial

Scandinavian journal of rheumatology, 2019-01, Vol.48 (1), p.9-16

2019

Volltextzugriff (PDF)

Monitoring total-body inflammation and damage in joints and entheses: the first follow-up study of whole-body magnetic resonance imaging in rheumatoid arthritis

Scandinavian journal of rheumatology, 2017-07, Vol.46 (4), p.253-262

2017

Volltextzugriff (PDF)

Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)

Annals of the rheumatic diseases, 2016-09, Vol.75 (9), p.1645-1653

2016

Volltextzugriff (PDF)

Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis

The pharmacogenomics journal, 2016-04, Vol.16 (2), p.141-146

2016

Volltextzugriff (PDF)

THU0212 Improved Remission Rates Acquired by Adding Adalimumab to Methotrexate and Intraarticular Glucocorticoid Cannot be Maintained after Withdrawal of Adalimumab. A 2-Year Investigator Initiated Randomised, Controlled Study on Early Rheumatoid Arthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A236-A236

2013

Volltextzugriff (PDF)

SAT0016 Microrna Expression Profiles as Biomarkers for Prediction of Treatment Response to Adalimumab in Patients with Early Rheumatoid Arthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A584-A584

2013

Volltextzugriff (PDF)

The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure

Rheumatology (Oxford, England), 2013-07, Vol.52 (7), p.1245-1253

2013

Volltextzugriff (PDF)

THU0478 Genome-Wide Association Analysis of Pain Reduction in Rheumatoid Arthritis Patients Treated with TNF Inhibitors

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.348-348

2014

Volltextzugriff (PDF)

FRI0148 Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis - 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA)

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.360-361

2013

Volltextzugriff (PDF)

Rapidly progressive endomyocardial fibrosis and heart failure in a 17-year-old female with limited cutaneous systemic sclerosis

Scandinavian journal of rheumatology, 2019, Vol.48 (4), p.336-337

2019

Volltextzugriff (PDF)

Genome-Wide Association Analysis of Pain Reduction in Rheumatoid Arthritis Patients Treated with TNF Inhibitors

ARTHRITIS & RHEUMATOLOGY, 2014, Vol.66, p.S1296

2014

Volltextzugriff (PDF)

GENOME-WIDE ASSOCIATION ANALYSIS OF PAIN REDUCTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TNF INHIBITORS

ANNALS OF THE RHEUMATIC DISEASES, 2014, Vol.73, p.348

2014

Volltextzugriff (PDF)

Treatment experiences with focus on IL-6R inhibition in patients with VEXAS-syndrome and a case of remission with azacytidine treatment

Rheumatology (Oxford, England), 2023-12

2023

Volltextzugriff (PDF)

Long-Term Risk of VTE in Sarcoidosis: A Nationwide Cohort Study

Chest, 2024-07, Vol.166 (1), p.136

2024

Volltextzugriff (PDF)

CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis

PloS one, 2012-06, Vol.7 (6), p.e38539

2012

Volltextzugriff (PDF)

Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis

Pharmacogenetics and genomics, 2012-08, Vol.22 (8), p.577-589

2012

Volltextzugriff (PDF)

Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects

Arthritis research & therapy, 2011-06, Vol.13 (3), p.R109-R109

2011

Volltextzugriff (PDF)

Long-Term Risk of VTE in Sarcoidosis

Chest, 2024-07, Vol.166 (1), p.136-145

2024

Volltextzugriff (PDF)

Tributylgermanium hydride as a replacement for tributyltin hydride in radical reactions

Organic & biomolecular chemistry, 2004-02, Vol.2 (4), p.585

2004

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(17)
Humans
(13)
Rheumatology
(13)
Female
(11)
Male
(11)
Middle Aged
(11)
Rheumatoid Arthritis
(10)
Adult
(9)
Arthritis, Rheumatoid - Drug Therapy
(9)
Aged
(8)
Adalimumab
(6)
Antirheumatic Agents - Therapeutic Use
(6)
Double-Blind Method
(6)
Treatment Outcome
(5)
Aged, 80 And Over
(4)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(4)
Arthritis, Rheumatoid - Genetics
(4)
Drug Therapy, Combination
(4)
Patients
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rapidly progressive endomyocardial fibrosis and heart failure in a 17-year-old female with limited cutaneous systemic sclerosis

Influence of low socioeconomic status on mortality in granulomatosis with polyangiitis

Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial

Monitoring total-body inflammation and damage in joints and entheses: the first follow-up study of whole-body magnetic resonance imaging in rheumatoid arthritis

Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)

Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab—a substudy of the optimized treatment algorithm in early RA (OPERA) trial

THU0212 Improved Remission Rates Acquired by Adding Adalimumab to Methotrexate and Intraarticular Glucocorticoid Cannot be Maintained after Withdrawal of Adalimumab. A 2-Year Investigator Initiated Randomised, Controlled Study on Early Rheumatoid Arthritis

SAT0016 Microrna Expression Profiles as Biomarkers for Prediction of Treatment Response to Adalimumab in Patients with Early Rheumatoid Arthritis

The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure

THU0478 Genome-Wide Association Analysis of Pain Reduction in Rheumatoid Arthritis Patients Treated with TNF Inhibitors

FRI0148 Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis - 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA)

Rapidly progressive endomyocardial fibrosis and heart failure in a 17-year-old female with limited cutaneous systemic sclerosis

Genome-Wide Association Analysis of Pain Reduction in Rheumatoid Arthritis Patients Treated with TNF Inhibitors

GENOME-WIDE ASSOCIATION ANALYSIS OF PAIN REDUCTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TNF INHIBITORS

Treatment experiences with focus on IL-6R inhibition in patients with VEXAS-syndrome and a case of remission with azacytidine treatment

Long-Term Risk of VTE in Sarcoidosis: A Nationwide Cohort Study

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial

Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeans

CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis

Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis

A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial

Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects

Long-Term Risk of VTE in Sarcoidosis

Tributylgermanium hydride as a replacement for tributyltin hydride in radical reactions

Suchergebnisse filtern